cytarabine has been researched along with technetium tc 99m exametazime in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bok, B; Bonnin, F; Duval, M; Elmaleh, M; Rohrlich, P; Stiévenart, JL; Véra, P; Vilmer, E | 1 |
Ahonen, A; Harila-Saari, A; Jauhiainen, J; Lanning, M; Lehtinen, S; Pääkkö, E; Pyhtinen, J; Torniainen, P | 1 |
2 other study(ies) available for cytarabine and technetium tc 99m exametazime
Article | Year |
---|---|
Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Brain; Brain Diseases; Cerebellum; Child; Child, Preschool; Cytarabine; Drug Monitoring; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neurologic Examination; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |
Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Child; Child, Preschool; Cytarabine; Female; Humans; Iatrogenic Disease; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Vincristine | 2003 |